InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: abeta post# 104243

Friday, 02/24/2017 11:23:24 AM

Friday, February 24, 2017 11:23:24 AM

Post# of 692393
abeta....Doclogic has posted numerous times on benefit of NWBO's CXCR-4 patent and benefits of it. I hope Doclogic sees this and will reply.


Message in reply to:

Did we just get this patent - or are we applying for it?

9,566,294
February 14, 2017

If this is OLD NEWS - sorry for the intrusion .....

Quote:
The present invention relates to the identification of a novel role of CXCR-4 in cell transformation and aberrant cellular proliferation. In particular, the present invention relates to the altered gene expression of CXCR-4 in a number of primary tumors and cell lines derived from tumors, in addition to, the altered gene expression of ligands for CXCR-4. Further, the present invention relates, in part, to the Applicants' surprising discovery that the inhibition of CXCR-4 gene expression or the inhibition of CXCR-4 activity in transformed cells reverses the transformed phenotype.



insert-text-here

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News